Complement C3 Cleavage and Cytokines Interleukin‐1β and Tumor Necrosis Factor‐α in Otitis Media With Effusion
Authors:
Open Access
- 1 October 2000
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 110 (10) , 1745-1749
Abstract
Objectives To analyze whether complement C3a anaphylatoxin, other C3 fragments, interleukin-1β (IL-1β), or tumor necrosis factor-α (TNF-α) contributes to inflammation in chronic otitis media with eff...Keywords
This publication has 18 references indexed in Scilit:
- Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusionClinical and Experimental Immunology, 1999
- Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cellsEuropean Journal of Immunology, 1996
- C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired ImmunityScience, 1996
- Cytokines, Immunoglobulins, and Bacterial Pathogens in Middle Ear EffusionsJAMA Otolaryngology–Head & Neck Surgery, 1995
- Interleukin‐8 expression in otitis mediaThe Laryngoscope, 1994
- Characterization of cytokines present in middle ear effusionsThe Laryngoscope, 1991
- Terminal Complement Complexes and Anaphylatoxins in Septic and Ischemic PatientsArchives of Surgery, 1988
- Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.Journal of Experimental Medicine, 1985
- Complement Anaphylatoxins Activity in Middle Ear EffusionAuris Nasus Larynx, 1985
- Complement in Chronic Secretory Otitis Media: C3 Breakdown and C3 Splitting ActivityJAMA Otolaryngology–Head & Neck Surgery, 1984